MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-24-0012369
Aden Pharmaceuticals Private Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹13.86 Cr
▲ 6% YoY
Net loss · FY 2025
₹20.31 Lakh
Net margin -1.5%
EBITDA · FY 2025
₹70.87 Lakh
EBITDA margin 5.1%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Open charges
₹7.42 Cr
Satisfied ₹10.18 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
31
Provident fund records
About Aden Pharmaceuticals Private Limited
Data last updated:
Aden Pharmaceuticals Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 August 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24232GJ2006PTC048957. Its GSTIN is 24AAFCA9288A1ZR (Gujarat).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Hasmukhbhai Madhabahi Antala and Ashokbhai Gobarbhai Savalia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block No. 563 /A Ecpl Road At. Dudhvada Ta. Padra, Vadodara, Gujarat, India – 391450.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.86 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net loss of ₹20.31 Lakh (net margin -1.5%) and EBITDA of ₹70.87 Lakh (EBITDA margin 5.1%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 2% over five years.
The company has about 31 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aden Pharmaceuticals. As per MCA filings, the company has open charges of ₹7.42 Cr and satisfied charges of ₹10.18 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
Aden Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0012369). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website adenpharma.net.
Company details
CIN U24232GJ2006PTC048957
Registration Number 048957
Incorporation Date 28 August 2006
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-24-0012369
Key People
Hasmukhbhai Madhabahi Antala Director Ashokbhai Gobarbhai Savalia Director Dilipkumar Shambhubhai Dholaria Director Recognitions & Rankings of Aden Pharmaceuticals
Contact details
Aden Pharmaceuticals Private Limited's registered office is in Vadodara, Gujarat. Its website is adenpharma.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressBlock No. 563 /A Ecpl Road At. Dudhvada Ta. Padra, Vadodara, Gujarat, India – 391450
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aden Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Aden Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Aden Pharmaceuticals operates one associated brand: Aden Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in manufacturing APIs and pharmaceutical intermediates for the healthcare industry. | adenpharma.net |
Business activity
The main business activity of Aden Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aden Pharmaceuticals Private Limited, buy the company report.
Financials of Aden Pharmaceuticals Private Limited
FY 2025 filings availableAden Pharmaceuticals Private Limited reported revenue of ₹13.86 Cr (up 6% YoY) for FY 2025.
Revenue · FY 2025
₹13.86 Cr ▲ 6%
Net loss · FY 2025
₹20.31 Lakh margin -1.5%
EBITDA · FY 2025
₹70.87 Lakh margin 5.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▼ 6%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▼ 24%
5 years · compounded
▼ 15%
Revenue rose 6% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹70.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹20.31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | ||||
| Net Profit Margin | -1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aden Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aden Pharmaceuticals Private Limited
Aden Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hasmukhbhai Madhabahi Antala Also directs: Venture Pharmaceuticals Private Limited | Director | 03 Jan 2008 | 18 Years 9 Months | Current |
| Ashokbhai Gobarbhai Savalia | Director | 28 Aug 2006 | 20 Years 2 Months | Current |
| Dilipkumar Shambhubhai Dholaria | Director | 28 Aug 2006 | 20 Years 2 Months | Current |
Peer comparison
Aden Pharmaceuticals Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stereokem Private Limited | ₹13.93 Cr (FY 2024) | 29.0% | Hyderabad, Telangana, India | |||
| Santis Pharmaceuticals Private Limited | ₹13.9 Cr (FY 2021) | 14.0% | Ahmedabad, Gujarat, India | |||
| DJ Pharmaceuticals Private Limited | ₹13.89 Cr (FY 2020) | 14.0% | Ahmedabad, Gujarat, India | |||
| Aksharam Pharma Private Limited | ₹13.87 Cr (FY 2024) | 39.0% | Wadhwancity, Gujarat, India | |||
| Aden Pharmaceuticals Private Limitedthis company | ₹13.86 Cr (FY 2025) | -₹20.31 Lakh | -1.5% | 6.0% | 31 | Vadodara, Gujarat, India |
| PLG Pharmaceuticals Private Limited | ₹13.84 Cr (FY 2024) | -20.0% | Delhi, India | |||
| J. B. Remedies Private Limited | ₹13.82 Cr (FY 2024) | 12.0% | Roorkee, Uttarakhand, India | |||
| Haustus Bio Tech Private Limited | ₹13.81 Cr (FY 2025) | -3.0% | Himachal Pradesh, India | |||
| Doctor Auxiliary Private Limited | ₹13.77 Cr (FY 2025) | 8.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Aden Pharmaceuticals Private Limited, buy the company report.
Auditor
Aden Pharmaceuticals Private Limited is audited by K. A. Tilwani & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K. A. Tilwani & Associates | FY 2023 | 138159W |
Shareholding
The shareholding of Aden Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aden Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹7.42 Cr
Satisfied charges
₹10.18 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Dec 2024 | 101017024 | Bank of India | ₹3.71 Cr | Open | |
| 27 Feb 2024 | 100872116 | Bank of India | ₹3.71 Cr | Open | |
| 12 May 2017 | 100099265 | Others | ₹3.43 Cr | Satisfied | |
| 11 Apr 2017 | 100099262 | Others | ₹2.3 Cr | Satisfied | |
| 02 Apr 2013 | 10422836 | Bank of India | ₹1 Cr | Satisfied |
To see the full charge records of Aden Pharmaceuticals Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Aden Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by Government of Gujarat | Disposed |
To see the full case history of Aden Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aden Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aden Pharmaceuticals Private Limited has a workforce of 31 employees on its EPFO records as of Sep 25, 2025, across 1 active EPFO establishment.
Employee count
31
Active EPFO establishments
1
GST
Aden Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAFCA9288A1ZR | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aden Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aden Pharmaceuticals Private Limited has 7 board changes on record since 2006: 3 appointments and 4 cessations. The latest: Alpaben Hasmukhbhai Antala ceased to be Director on 01 Apr 2015.
AGM
Aden Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aden Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Bank Of India amounted to Rs. 370.98 Lakh with Charge ID 101017024 was registered on 05 Dec 2024.
Charges
A charge with Bank Of India of Rs. 370.98 Lakh registered on 27 Feb 2024 with Charge ID 100872116 was modified on 05 Dec 2024.
Charges
A charge registered on 02 Apr 2013 via Charge ID 10422836 with Bank Of India was fully satisfied on 14 Mar 2024.
Charges
A charge registered on 06 Dec 2008 via Charge ID 10135028 with Bank Of India was fully satisfied on 14 Mar 2024.
Charges
A charge registered on 06 Dec 2008 via Charge ID 10135307 with Bank Of India was fully satisfied on 14 Mar 2024.
Charges
A charge with Bank Of India amounted to Rs. 370.98 Lakh with Charge ID 100872116 was registered on 27 Feb 2024.
Charges
A charge registered on 12 May 2017 via Charge ID 100099265 with Others was fully satisfied on 09 Feb 2024.
Charges
A charge registered on 11 Apr 2017 via Charge ID 100099262 with Others was fully satisfied on 09 Feb 2024.
Charges
A charge with Others of Rs. 229.66 Lakh registered on 11 Apr 2017 with Charge ID 100099262 was modified on 09 Nov 2023.
Charges
A charge with Others of Rs. 343.46 Lakh registered on 12 May 2017 with Charge ID 100099265 was modified on 26 Jul 2021.
15 earlier events are in the company report.
Frequently asked questions
Aden Pharmaceuticals is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 August 2006 (20+ years old) and is registered under CIN U24232GJ2006PTC048957.
Aden Pharmaceuticals has 3 current directors:
- Hasmukhbhai Madhabahi Antala - Director
- Ashokbhai Gobarbhai Savalia - Director
- Dilipkumar Shambhubhai Dholaria - Director
The latest financial statements of Aden Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aden Pharmaceuticals is 24AAFCA9288A1ZR, registered in Gujarat.
The CIN (Corporate Identification Number) of Aden Pharmaceuticals is U24232GJ2006PTC048957. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aden Pharmaceuticals has 1 court case on record: 1 filed against it.
Aden Pharmaceuticals was incorporated on 28 August 2006, making it 20+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Aden Pharmaceuticals by revenue are Stereokem Private Limited, Santis Pharmaceuticals Private Limited, DJ Pharmaceuticals Private Limited, Aksharam Pharma Private Limited, PLG Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Alpaben Hasmukhbhai Antala ceased to be Director on 01 Apr 2015. Bharti Ashok Savalia ceased to be Director on 01 Apr 2015. Hetalben Dilipbhai Dholariya ceased to be Director on 01 Apr 2015. Aden Pharmaceuticals has 7 board changes on record in total.
Yes, Aden Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-24-0012369).
Aden Pharmaceuticals can be reached through the website adenpharma.net. Its registered office is in Vadodara, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages